Studies in Alzheimer's disease models have shown that METTL3 stabilizes mRNAs to facilitate the clearance of phosphorylated Tau,52 and its overexpression in vivo reduces β‐amyloid‐induced synaptic damage and cognitive deficits.116. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.